Participant flow

Safety of PCI-32765 in Chronic Lymphocytic Leukemia · Source last updated 2014-03-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   PCI-32765: 420 mg daily or 840 mg daily.

   id

   FG000

   title

   PCI-32765

2. description

   PCI-32765: 420 mg daily

   id

   FG001

   title

   Food Effect Cohort

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         116

      2. group Id

         FG001

         num Subjects

         16

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         79

      2. group Id

         FG001

         num Subjects

         16

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         37

      2. group Id

         FG001

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

There are total 133 subjects enrolled however one subject never received treatment. Therefore, number of subjects "Started" the study is listed as 132 subjects.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice